Dasatinib 100 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FFFQ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,651
Award facts
- Contract value 100% obligated
- $20,651.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $20.7K to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The award was made through open competition with no set-aside designation, and performance will occur at the contractor's facility in Conshohocken, Pennsylvania. Dasatinib is a tyrosine kinase inhibitor used primarily in the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia, making this procurement critical for military and federal healthcare system requirements.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $1 billion global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and established federal contractor, AmerisourceBergen maintains a significant presence in the federal medical supply chain, supplying specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to the Defense Health Agency and other government healthcare systems. The delivery order's expedited completion timeline reflects the critical nature of pharmaceutical procurement for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FFFQ9?
SPE2DB25FFFQ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FFFQ9 worth?
The government has obligated $20,651 on SPE2DB25FFFQ9.
Is contract SPE2DB25FFFQ9 an order under another contract?
Yes. SPE2DB25FFFQ9 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFFQ9 competed?
The extent of competition for SPE2DB25FFFQ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award